1. Home
  2. MNKD vs DX Comparison

MNKD vs DX Comparison

Compare MNKD & DX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MannKind Corporation

MNKD

MannKind Corporation

HOLD

Current Price

$2.78

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo Dynex Capital Inc.

DX

Dynex Capital Inc.

HOLD

Current Price

$13.07

Market Cap

2.8B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
MNKD
DX
Founded
1991
1987
Country
United States
United States
Employees
N/A
22
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.8B
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
MNKD
DX
Price
$2.78
$13.07
Analyst Decision
Buy
Buy
Analyst Count
7
3
Target Price
$8.64
$14.25
AVG Volume (30 Days)
6.6M
5.1M
Earning Date
05-29-2026
01-01-0001
Dividend Yield
N/A
15.30%
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$348,966,000.00
N/A
Revenue This Year
$33.40
N/A
Revenue Next Year
$16.48
N/A
P/E Ratio
$140.75
$5.66
Revenue Growth
22.23
N/A
52 Week Low
$2.52
$10.79
52 Week High
$6.51
$14.93

Technical Indicators

Market Signals
Indicator
MNKD
DX
Relative Strength Index (RSI) 23.75 27.32
Support Level N/A $12.30
Resistance Level $6.08 $13.72
Average True Range (ATR) 0.37 0.30
MACD -0.05 -0.06
Stochastic Oscillator 7.79 18.94

Price Performance

Historical Comparison
MNKD
DX

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About DX Dynex Capital Inc.

Dynex Capital Inc is an internally managed mortgage real estate investment trust, which invests in mortgage-backed securities. The company invests in residential and commercial mortgage-backed securities. Its objective is to provide attractive risk-adjusted returns to shareholders over the long term that are reflective of a leveraged, high quality fixed income portfolio with a focus on capital preservation. Its investments consist principally of Agency mortgage-backed securities including, residential MBS and commercial MBS.

Share on Social Networks: